# Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic Variants

> clinical trial · VERIFIED · 2026-08-14

Status: NOT_YET_RECRUITING · Sponsor: Weill Medical College of Cornell University · Condition: Ovarian Neoplasms

- Company: Weill Medical College of Cornell University
- Sector: diagnostics
- Primary source: https://clinicaltrials.gov/study/NCT07764744

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.